CYTOTRON
 
  Shréis-Scalene
Cytotron
Arthritis
Cancer                            Multiple Sclerosis
Clinical Studies
Scientific Research
Inventor                         The Team
FAQ                              
In The News
 
 
 
 

Shreis-Scalene Sciences
11516 Darnestown Rd. Gaithersburg,MD 20878
Tel : (001)301-926-0566
Fax : (001)301-926-2925
email : Shréis.com

 

 

Frequently Asked Questions

Will there be nay sayers and skeptics to the technology?

Sure. Like any technology in medical history!   Do we have all the answers? No. It is good to be skeptical.  But preaching theory alone all our lives does not bring relief or life to a patient.  We need a solution for a problem.  In the practice of medicine, patients are looking for relief and if possible a cure. The country, the world is looking for it.  The Cytotron is a step in the right direction.   The Cytotron may not be everything to everyone.  But when we talk to the patients whose knee cartilages have grown, and when we look at cancer patients having a longer lease on life or when we see MS patients having a better quality of life,  that speaks for itself and we do our best to explain to the skeptics. We do not worry too much about the nay sayers.  We have to live with them.

 

CANCER

Osteo Arthritis

In which types of cancer is RFQMR applicable  ?
RFQMR treatment can be applied locally on tumors not to the body general as a systemic treatment. Three different tumors in close regions can be targeted simultaneously. In wide spread metastasis, in leukemia and skin cancers RFQMR can not be used.  During the clinical trials, best outcome has been observed on brain tumors, pancreatic cancer, non small cell lung cancer, liver cancer, kidney cancer, colon cancer, ovarian cancer, prostate cancer and laryngeal cancer.   Currently there in not enough clinical evidence that RFQMR should be used in breast cancer, bone cancer, lymphoma, non small cell lung cancer, sarcoma, head and neck cancer.

                      Top

What is the effect of RFQMR on the tumors and on the overall disease condition?
In those patients responding to the treatment within the first week there is a significant reduction in tumor activity accompanied by a decrease in the intensity of pain and most patients are able to stop taking painkillers including morphine. As of the second week the appetite comes back, and also an increase in the overall energy level and weight gain is expected.  The major aim of the RFQMR therapy is not the immediate destruction of the tumor but rather suppressing the growth and activity. Following the treatment the cancer cells gets into a vegetative state and in time the programmed cell death –apoptosis- takes place. After the treatment what is expected is that the borders of the tumors should be more defined, the tumor density should be reduced, the tumor activity should halt, and there is some shrinkage and subsequent volume reduction of the tumor. Athough a long period is required for the complete elimination of the tumor, the inactivated tumor mass does not pose any further health risks.

                                                                       Top

Can RFQMR be used along with other therapies for cancer?
Currently the recognized modalities for cancer treatment are surgery, radiotherapy and chemotherapy.  RFQMR should never be substituted for a treatment advised by a competent doctor for the patient. Nevertheless in those patients that do not respond to conventional therapies, and in such patients where the efficacy of the conventional therapies need to be enhanced RFQMR can be used along with other treatment modalities.  If applied prior to the surgery, the borders of tumor will be more defined and the activity will be less so the surgery could be more precisely undertaken. Also future metastasis and recurrence could  be prevented. Post surgery RFQMR may be used to control the remainder of the tumors that may not be fully cleared during the surgery. Combined with chemotherapy RFQMR may help to control the tumors more effectively in the applied area.  As it works through different mechanisms RFQMR can be used along with other Complementary or Alternative Therapies. 

                                                Top

How does the RFQMR cancer treatment process takes places?
In order to determine the suitability of the RFQMR treatment we need to obtain a dossier that contains personalized information of the patient such as age, sex, weight etc, the diagnosis and the prognosis of the disease based on previous investigations, therapies applied and the outcome, the current situation of the patient with detailed symptoms,  test results and the diagnostic images such as MRI, CT Scan, X-Ray etc (preferably in DICOM format on a CD). There will be an initial evaluation of the patient, and if RFQMR is applicable there will be a further appointment with our doctors to discuss the terms and expected outcomes of the treatment.   Prior to the treatment the MRI of the area where treatment will be focused is obtained and will be fed to the Cytotron system. Afterwards based on the proton density of the tumors the system will make an automated dose planning. Depending on the size and type of the tumor and patient’s overall health condition the treatment will be made either as a 28 days 1 hour session or 14 days on 14 days break 14 days on session. If deemed necessary, the chemotherapy along with the RFQMR treatment will be provided under the supervision of our Oncologist.

                                                                  Top

Is there a side effect of RFQMR treatment on cancer patients?
No significant side effect has been noticed in the  patients that participated in the Phase 1 clinical trial. In very few patients minor issues such as temporary redness itching has been observed. The patient does not feel anything during the treatment.  RFQMR does not utilize the ionizing, thermal, destructive radiation of the upper side of the electromagnetic spectrum such those used in radiotherapy including X-rays or gamma knife that damages the DNAs and may also adversely affect the healthy cells. The non-ionizing, non-thermal radio frequency waves utilized in RFQMR has been safely used in thousands of electrical devices for more that 100 years and the MRI technology that has been utilized to precisely focus the rays on the application area has been in wide spread use for more than 30 years. In order to prevent the adverse affects that may take place do to the rapid necrosis of the dying tumor, the treatment can be split into two if necessary.   

                                                                                                                        Top

In which types of arthritis is RFQMR applicable?
The RFQMR treatment has been applied to osteoarthritis patients on the clinical trials. Mostly conditions related to a damaged or detoriated cartilage responds best to RFQMR treatment. Although positive responses has been noticed on patients with Rheumatoid arthritis, the long term success of this improvement is currently unknown as the number and the duration is limited.
There is no direct effect of RFQMR on ligaments, meniscuses or thorn muscles. However once the joint’s condition is improved with treated cartilage further benefits can be obtained with the help of physiotherapy where the strength of the muscle groups can be improved. Currently the RFQMR can be applied on both knees, or hips, or shoulders, or elbows.                          

Top


What is the effect of RFQMR on cartilage and the overall condition of the joint?
In patients responding the treatment, there is a noticeable reduction in pain and improvement in mobility after 10-15 sessions. By the end of 21 sessions most patients should be free of pain and not requiring any pain killers. There is a significant improvement in joint mobility. Even patients who can hardly walk a few steps or those who are bedridden may walk longer distances without pain. But yet the overall efficacy is based on several factors including other conditions that may affect the joint.  The regenerative effect of RFQMR on cartilage is expected to continue once the treatment period is over. The 21 day sessions are required to initiate the regeneration process by increasing the membrane potential of the cells to a level where command and control center can issue orders for cell division.  During the clinical trials measurable regeneration has been observed on MRI scans 90 days post treatment period and this situation continues even nine months after the treatment is over. As a result continual improvement is expected for a considerable time frame.

Top

How does the RFQMR arthritis treatment process takes place?
In order to determine the suitability of the RFQMR treatment we need to obtain a dossier that contains personalized information of the patient such as age, sex, weight etc, the diagnosis and the prognosis of the disease based on previous investigations, therapies applied and the outcome, the current situation of the patient with detailed symptoms,  test results and the diagnostic images such as MRI,  X-Ray etc (preferably in DICOM format on a CD). There will be an initial evaluation of the patient, and if RFQMR is applicable there will be a further appointment with our doctors to discuss the terms and expected outcomes of the treatment. Prior to the treatment the MRI of the area where treatment will be focused is obtained and will be fed to the Cytotron system. Afterwards the system will make an automated dose planning.The therapy will take place as a continuous 21 day sessions of 30 minutes each for knee and 60 minutes each for hip osteoarthritis patients.

                                                                                                                                Top

Is there a side effect of RFQMR treatment on arthritis patients?
Over the last 3 years no significant side effect has been noticed in the  patients that participated in the clinical trials and obtained treatment. In very few patients minor issues such as temporary redness itching has been observed. The patient does not feel anything during the treatment.

RFQMR does not utilize the ionizing, thermal, destructive radiation of the upper side of the electromagnetic spectrum such those used in radiotherapy including X-rays or gamma knife that may also adversely affect the healthy cells. The non-ionizing, non-thermal radio frequency waves utilized in RFQMR has been safely used in thousands of electrical devices for more that 100 years and the MRI technology that has been utilized to precisely focus the rays on the application area has been in wide spread use for more than 30 years.                                                              

Top

 Is RFQMR treatment available in Europe and the USA?
Shréis-Scalene Sciences
is responsible for all distribution, scientific set ups, collaborations etc in the USA, Canada, and South American Countries.  Since the CE Mark Certification was received in July 2009 and accepted in Europe,  the Cytotron System is available in Europe.  Due to changes in the Medical Device Directive, recertification of all devices are on at this time.

                                                                                                                                             Top

In the NEWS 

RFQMR



The Hindu
Red Herring
Sibia
Living
Deccan Herald

Haemoseis-256

The Hindu            Healthcare Mgt
IEEE
Business Line
Indo-American
Deccan Herald     PharmaBiz

 

Engineering Solutions to Human Problems